VU0650786
VU0650786 Basic information
- Product Name:
- VU0650786
- Synonyms:
-
- VU0650786
- Pyrazolo[1,5-a]pyrazin-4(5H)-one, 2-[[(5-chloro-2-pyridinyl)oxy]methyl]-5-(2-fluoro-3-pyridinyl)-6,7-dihydro-7-methyl-, (7R)-
- inhibit,anxiolytic activity,antidepressant,Inhibitor,VU-0650786,mGlu3 NAM,VU0650786,mGluR,Metabotropic glutamate receptors,VU 0650786
- (7R)-2-{[(5-chloropyridin-2-yl)oxy]methyl}-5-(2-fluoropyridin-3-yl)-7-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one
- VU0650786, 10 mM in DMSO
- CAS:
- 1809085-30-0
- MF:
- C18H15ClFN5O2
- MW:
- 387.8
- Mol File:
- 1809085-30-0.mol
VU0650786 Chemical Properties
- Boiling point:
- 587.4±50.0 °C(Predicted)
- Density
- 1.49±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : 250 mg/mL (644.66 mM);Water : < 0.1 mg/mL (insoluble)
- form
- Solid
- pka
- 0.99±0.22(Predicted)
- color
- White to off-white
VU0650786 Usage And Synthesis
Uses
VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM. VU0650786 has antidepressant and anxiolytic activity in rodents[1].
in vivo
VU0650786 (VU786) (i.p., 30 mg/kg) increases the proportion of c-Fos-positive cells by approximately 4-fold, enhances synaptic strength in cone cell subpopulations, weakens thalamocortical long-term depression (LTD), and reduces passive coping in acute models of antidepressant-like activity in inducible cFos-EGFP mice[2].
The pharmacokinetic parameters of VU0650786 (compound 106) in rats[1].
| Parameters | IV (0.2 mg/kg) |
| t1/2 (min) | 42 |
| CL plasma (mL/min/kg) | 37 |
| VSS (L/kg) | 1.6 |
IC 50
mGluR3: 392 nM (IC50)
References
[1] Engers JL, et al. Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. J Med Chem. 2015 Sep 24;58(18):7485-500. DOI:10.1021/acs.jmedchem.5b01005
[2] Max E Joffe, et al. mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. Neuron. 2020 Jan 8;105(1):46-59.e3. DOI:10.1016/j.neuron.2019.09.044
VU0650786Supplier
- Tel
- 021-52996696,15000506266 15000506266
- Tel
- 13816613772
- huahero21@sina.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- +86-13301875428
- sales@changyuhe.com
- Tel
- 15911056312
- liming@bio-fount.com
VU0650786(1809085-30-0)Related Product Information
- N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide
- VU0134992(hydrochloride)
- VU6005649
- VU 591 hydrochloride
- VU0810464
- VU0483605
- N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide
- 1-(4-Methoxybenzyl)-5-trifluoromethoxyisatin
- VU 6008667
- (1R,2R)-N-([S]-1-{4-[5-broMo-2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxaMide
- 5-Amino-3,4-dimethyl-thieno[2,3-c]pyridazine-6-carboxylic acid 4-trifluoromethanesulfonyl-benzylamide
- 3-methylsulfanyl-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine
- VU 0360172
- VU 0365114
- VU 0357121
- VU 0360223
- VU 0364439
- VU0661013